Back

CCMHFpEF: Is CCM Therapy safe and effective in patients with HFpEF?

22 May 2022 (10:35 - 10:45)
Organised by:
Congress Presentation Part of: Late-Breaking Clinical Trial - Devices Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2022

About the speaker

Photo
Professor Cecilia Marianne Linde

Karolinska Institute, Stockholm (Sweden)

3 More presentations in this session

Presentation thumbnail
ENDO-HF Neuromodulation in Heart Failure
Professor A. Stewart Coats (Sydney, AU)
Slides Video
Presentation thumbnail
REBALANCE-HF Roll In Cohort
Doctor M. Fudim (Durham, US)
Slides Video
Presentation thumbnail
GHIDD - Glycemic variability and hyperglycemia in HFpEF
Professor G. Fazio (Palermo, IT)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Clinical Trial - Devices
Video

The Event

Event poster

Heart Failure 2022

22 May 2022 10:35 CET
You may be interested in
thumbnail
Congress Presentation
Introduction to CCM: how does it work, and what can it do?
26 August 2022
thumbnail
Congress Presentation
What on earth is HFpEF?
1 September 2024
thumbnail
Congress Session
Late breaking clinical trials: devices
12 May 2024
thumbnail
Congress Presentation
Welcome and introduction
30 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources